InspireMD Inc. (NSPR): Price and Financial Metrics


InspireMD Inc. (NSPR)

Today's Latest Price: $0.39 USD

0.00 (0.36%)

Updated Dec 4 8:00pm

Add NSPR to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 369 in Miscellaneous

See all "A" rated Strong Buy stocks

NSPR Stock Summary

  • NSPR has a market capitalization of $14,116,716 -- more than approximately just 5.68% of US stocks.
  • The ratio of debt to operating expenses for InspireMD Inc is higher than it is for about just 11.28% of US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for NSPR comes in at -87.35% -- higher than that of only 4.1% of stocks in our set.
  • Stocks that are quantitatively similar to NSPR, based on their financial statements, market capitalization, and price volatility, are SCON, CPIX, RMTI, TOUR, and GIGM.
  • NSPR's SEC filings can be seen here. And to visit InspireMD Inc's official web site, go to www.inspiremd.com.

NSPR Stock Price Chart Interactive Chart >

Price chart for NSPR

NSPR Price/Volume Stats

Current price $0.39 52-week high $1.64
Prev. close $0.39 52-week low $0.28
Day low $0.38 Volume 1,255,062
Day high $0.41 Avg. volume 1,814,511
50-day MA $0.35 Dividend yield N/A
200-day MA $0.53 Market Cap 14.36M

NSPR Latest News Stream


Event/Time News Detail
Loading, please wait...

NSPR Latest Social Stream


Loading social stream, please wait...

View Full NSPR Social Stream

Latest NSPR News From Around the Web

Below are the latest news stories about InspireMD Inc that investors may wish to consider to help them evaluate NSPR as an investment opportunity.

InspireMD to Report Second Quarter 2020 Financial Results on Wednesday, August 5, 2020 and Provide Corporate Update

Conference Call to be held Thursday, August 5, 2020 at 8:30am ET

GlobeNewswire | July 28, 2020

InspireMD Gains Registration Clearance of its CGuard™ Embolic Prevention System (EPS) in Brazil

TEL AVIV, Israel, July 23, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announced it has obtained registration from the Brazilian registration authority, Agéncia Nacional de Vigiláncia Sanitária (ANVISA), for its CGuard™ MicroNet®\- covered stent, clearing it for sale and distribution in Brazil.“As the largest market for medical devices in Latin America and one of the top overall global markets for carotid artery disease, the Brazilian registration clearance for CGuard™ is an important accomplishment for our company and represents a significant opportunity to serve an emerging healthcare system. The global carotid artery disease m...

Yahoo | July 23, 2020

InspireMD Announces Late-Breaking Presentation of Early SIBERIA Clinical Trial Results to be Featured in an e-Course at EuroPCR

TEL AVIV, Israel, June 25, 2020 -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by.

Yahoo | June 25, 2020

InspireMD, Inc. Announces Underwriter Exercise of Over-Allotment Option in Full and Closing of $11.5 Million Follow-On Underwritten Public Offering

InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, announced today the closing, on June 5, 2020, of its $11.5 million follow-on underwritten public offering, which included $1.5 million from the exercise, in full, by the underwriter of its over-allotment option for the offering. Pursuant to the offering, InspireMD issued 25,555,500 shares of common stock or common stock equivalents, along with an equivalent number of Series F warrants to purchase common stock, in units, at a price to the public of $0.45 per unit. Each Series F warrant is exercisable for one share of common stock at an exercise price of $0.495 per share.

Yahoo | June 8, 2020

Edited Transcript of NSPR earnings conference call or presentation 12-May-20 12:30pm GMT

Q1 2020 InspireMD Inc Earnings Call

Yahoo | June 4, 2020

Read More 'NSPR' Stories Here

NSPR Price Returns

1-mo 12.23%
3-mo 14.37%
6-mo -28.00%
1-year -55.00%
3-year -99.83%
5-year -100.00%
YTD -63.89%
2019 -86.42%
2018 -96.45%
2017 -94.88%
2016 -88.64%
2015 -88.72%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8092 seconds.